Patient perception and treatment convenience of dabigatran versus vitamin K antagonist when used for stroke prophylaxis in atrial fibrillation: Real-world Evaluation of Long-term Anticoagulant Treatment Experience (RE-LATE) study

PURPOSE: Dabigatran is a direct thrombin inhibitor approved for stroke prophylaxis in patients with non-valvular atrial fibrillation (NVAF). Real-world data about patient preference, satisfaction and convenience in patients in Asia are not available. The study aimed to explore the perception of pati...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Young-Soo, Oh, Yong Seog, Choi, Eue-Keun, Chern, Alan Koay Choon, Jiampo, Panyapat, Chutinet, Aurauma, Hanafy, Dicky Armein, Trivedi, Prabhav, Zhai, Dongmei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Aortic and Vascular Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640669/
https://www.ncbi.nlm.nih.gov/pubmed/34857666
http://dx.doi.org/10.1136/openhrt-2021-001745

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8640669/
https://www.ncbi.nlm.nih.gov/pubmed/34857666
http://dx.doi.org/10.1136/openhrt-2021-001745

Ejemplares similares